BURNING ROCK BIOTECH LIMITED

Business Segments Burning Rock Biotech Limited

Stocks

BNR

US12233L2060

Healthcare Facilities & Services

Market Closed - Nasdaq 16:30:00 2026-08-28 EDT			5-day change	1st Jan Change
10.19 ^USD	+1.90%		+4.19%	-49.43%

07-20	Burning Rock Biotech Limited and Myriad Genetics Announce Global Strategic Technology Licensing Partnership to Expand Hrd Testing Worldwide	CI
07-02	Burning Rock Biotech Insider Bought Shares Worth $6,182,172, According to a Recent SEC Filing	MT

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Gross Profit: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (CNY)

Fiscal Period: December	2017	2018	2019	2020	2021	2022	2023	2024	2025
Drug Delivery Technologies
In-Hospital Channel					165M	175M	189M	224M	224M
Gross Profit					115M	112M	116M	159M	167M
					-	-	-	-	224M
Pharmaceutical Contract Laboratories
Central Laboratory Channel					319M	315M	233M	176M	160M
Gross Profit					238M	233M	183M	142M	138M
					-	-	-	-	160M
Pharmaceutical Contract Research Organization
Pharma Research and Development Channel					23.39M	73.17M	116M	116M	156M
Gross Profit					11.08M	35.39M	63.76M	61.17M	98.64M
					-	-	-	-	156M

Geographical breakdown of sales (CNY)

Fiscal Period: December	2017	2018	2019	2020	2021	2022	2023	2024	2025
Mainland China					-	-	-	-	439M
Overseas					-	-	-	-	101M
					-	-	-	-	439M
United States					-	9.93M	2.51M	5.58M	-
Total Assets					46.04M	34.13M	21.42M	6.11M	18.32M
					-	-	-	-	101M
People’s Republic of China (PRC)					-	553M	535M	510M	-
Total Assets					406M	287M	128M	102M	63.19M
Interest Expense					-	-	-	-	-
D&A					-	-	-	-	-
CAPEX					-	-	-	-	-
Gross Profit					-	-	-	-	-
Net Income					-	-	-	-	-
EBT					-	-	-	-	-
Operating Income					-	-	-	-	-

As early as today, start finding the best investment opportunities!